Analyst Ratings For Loxo Oncology (NASDAQ:LOXO)
Today, Stifel Nicolaus reiterated its Buy rating on Loxo Oncology (NASDAQ:LOXO) with a price target of $71.00.
There are 6 buy ratings on the stock.
The current consensus rating on Loxo Oncology (NASDAQ:LOXO) is Buy (Score: 3.00) with a consensus target price of $74.60 per share, a potential 3.90% upside.
Some recent analyst ratings include
- 8/3/2017-Stifel Nicolaus Reiterated Rating of Buy.
- 8/3/2017-BTIG Research Reiterated Rating of Buy.
- 6/19/2017-Morgan Stanley Reiterated Rating of Overweight.
- 6/5/2017-Cowen and Company Reiterated Rating of Outperform.
- 6/5/2017-Citigroup Inc. Upgrade from a “Neutral ” rating to a ” Buy” rating.
- 2/8/2017-Jefferies Group LLC initiated coverage with a Buy rating.
- 4/19/2016-Oppenheimer Holdings, Inc. Reiterated Rating of Outperform.
- On 5/22/2017 Keith T Flaherty, Director, sold 7,250 with an average share price of $45.09 per share and the total transaction amounting to $326,902.50. View SEC Filing
- On 1/10/2017 Aisling Capital Iii Lp, Major Shareholder, bought 160,000 with an average share price of $31.00 per share and the total transaction amounting to $4,960,000.00. View SEC Filing
- On 12/19/2016 Keith T Flaherty, Director, sold 7,250 with an average share price of $30.23 per share and the total transaction amounting to $219,167.50. View SEC Filing
- On 9/7/2016 Keith T Flaherty, Director, sold 14,500 with an average share price of $30.00 per share and the total transaction amounting to $435,000.00. View SEC Filing
- On 8/11/2016 Keith T Flaherty, Director, sold 15,000 with an average share price of $26.00 per share and the total transaction amounting to $390,000.00. View SEC Filing
- On 8/10/2016 David P Bonita, Director, sold 447,857 with an average share price of $26.96 per share and the total transaction amounting to $12,074,224.72. View SEC Filing
- On 5/17/2016 Aisling Capital Iii Lp, Major Shareholder, bought 232,558 with an average share price of $21.50 per share and the total transaction amounting to $4,999,997.00. View SEC Filing
Recent Trading Activity for Loxo Oncology (NASDAQ:LOXO)
Shares of Loxo Oncology closed the previous trading session at 71.80 up +1.33 1.89% with 233,565 shares trading hands.